JP2005507884A - 眼の感染の治療のためのオキサゾリジノン、例えばリネゾリドの全身投与 - Google Patents

眼の感染の治療のためのオキサゾリジノン、例えばリネゾリドの全身投与 Download PDF

Info

Publication number
JP2005507884A
JP2005507884A JP2003528621A JP2003528621A JP2005507884A JP 2005507884 A JP2005507884 A JP 2005507884A JP 2003528621 A JP2003528621 A JP 2003528621A JP 2003528621 A JP2003528621 A JP 2003528621A JP 2005507884 A JP2005507884 A JP 2005507884A
Authority
JP
Japan
Prior art keywords
formula
compound
mixture
pharmaceutically acceptable
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003528621A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005507884A5 (https=
Inventor
スラッター,ジェイ・グレッグ
Original Assignee
ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー filed Critical ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー
Publication of JP2005507884A publication Critical patent/JP2005507884A/ja
Publication of JP2005507884A5 publication Critical patent/JP2005507884A5/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541Non-condensed thiazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP2003528621A 2001-09-14 2002-09-11 眼の感染の治療のためのオキサゾリジノン、例えばリネゾリドの全身投与 Pending JP2005507884A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32215301P 2001-09-14 2001-09-14
US32211501P 2001-09-14 2001-09-14
PCT/US2002/025977 WO2003024528A1 (en) 2001-09-14 2002-09-11 Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections

Publications (2)

Publication Number Publication Date
JP2005507884A true JP2005507884A (ja) 2005-03-24
JP2005507884A5 JP2005507884A5 (https=) 2005-12-08

Family

ID=26983274

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003528621A Pending JP2005507884A (ja) 2001-09-14 2002-09-11 眼の感染の治療のためのオキサゾリジノン、例えばリネゾリドの全身投与

Country Status (12)

Country Link
US (2) US20030069235A1 (https=)
EP (1) EP1425068A1 (https=)
JP (1) JP2005507884A (https=)
KR (1) KR20040035769A (https=)
CN (1) CN1281211C (https=)
BR (1) BR0212466A (https=)
CA (1) CA2460360A1 (https=)
IL (1) IL160490A0 (https=)
MX (1) MXPA04002071A (https=)
NZ (1) NZ531353A (https=)
PL (1) PL370033A1 (https=)
WO (1) WO2003024528A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108283622A (zh) * 2018-04-03 2018-07-17 广州君博医药科技有限公司 一种缓释型利奈唑胺眼用药物及其制备方法
WO2021184339A1 (en) 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
CN1305374A (zh) * 1998-07-14 2001-07-25 法玛西雅厄普约翰美国公司 治疗眼部感染的噁唑烷酮
ATE337002T1 (de) * 1999-09-13 2006-09-15 Insite Vision Inc Topische behandlung zur vorbeugung von augeninfektionen
US6696426B2 (en) * 2000-08-22 2004-02-24 Pharmacia Corporation Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems
PE20020578A1 (es) * 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares

Also Published As

Publication number Publication date
WO2003024528A1 (en) 2003-03-27
US20030069235A1 (en) 2003-04-10
CA2460360A1 (en) 2003-03-27
IL160490A0 (en) 2004-07-25
MXPA04002071A (es) 2005-02-17
KR20040035769A (ko) 2004-04-29
NZ531353A (en) 2006-09-29
CN1545428A (zh) 2004-11-10
US20050234052A1 (en) 2005-10-20
HK1068564A1 (en) 2005-04-29
CN1281211C (zh) 2006-10-25
EP1425068A1 (en) 2004-06-09
PL370033A1 (en) 2005-05-16
BR0212466A (pt) 2004-10-19

Similar Documents

Publication Publication Date Title
US11684570B2 (en) Pharmaceutical ophthalmic compositions
JP7232128B2 (ja) 抗菌剤及び抗炎症剤を含む眼内投与のための医薬組成物
US11510916B2 (en) Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
CN116077665A (zh) 用于治疗眼科疾病和障碍的化合物
EA022040B1 (ru) Применение бетанехола для лечения ксеростомии
US20160175323A1 (en) Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
JP2006513217A (ja) 眼内用途のためのステロイド組成物
JP2019514975A (ja) 薬学的眼病用組成物およびそれを製造するための方法
US20160101118A1 (en) Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
US20190105320A1 (en) Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
WO2001017527A1 (en) Preventive and therapeutic agents for eye diseases
JP3502574B2 (ja) 眼感染症治療用眼軟膏剤
JP2019503335A (ja) ジメチルアミノミケリオリドの使用
JP2005507884A (ja) 眼の感染の治療のためのオキサゾリジノン、例えばリネゾリドの全身投与
US20210346318A1 (en) Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
WO2022132567A1 (en) Mydriatic compositions and methods for fabricating thereof
US9814673B2 (en) Intraocular lens comprising pharmaceutical compositions and methods for fabricating thereof
RU2812900C2 (ru) Анестезирующая композиция и способ анестезирования глаза
AU2002341559A1 (en) Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections
ZA200401995B (en) Treatment for ocular infections.
WO2020117497A1 (en) Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
EP1158981A1 (en) Use of remifentanyl for reducing blood pressure
HK1068564B (en) The use of oxazolidones substance in the preparation of a medicament for treating ophthalmic infection in mammal
CN112358477A (zh) 一种用于治疗胆囊炎的药物及其制备方法
JP2023507764A (ja) 1p36欠失症候群の治療的処置のためのガボキサドール

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080228

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080723